Eledon Pharmaceuticals annual depreciation and amortization
2012
2013
2014
2015
2016
2017
2018
2019
2020
2022
2023
2024
2025
Eledon Pharmaceuticals Depreciation & Amortization Growth & History (ELDN)
Eledon Pharmaceuticals's depreciation and amortization was $313,000 for fiscal 2025.
View full Eledon Pharmaceuticals company overviewEledon Pharmaceuticals annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $313,000 | −$46,000 | −12.81% |
| 2024 | 2024-12-31 | $359,000 | −$15,000 | −4.01% |
| 2023 | 2023-12-31 | $374,000 | $1,000 | +0.27% |
| 2022 | 2022-12-31 | $373,000 | — | — |
| 2020 | 2020-12-31 | $5,000 | −$4,000 | −44.44% |
| 2019 | 2019-12-31 | $9,000 | −$2,000 | −18.18% |
| 2018 | 2018-12-31 | $11,000 | −$11,000 | −50.00% |
| 2017 | 2017-12-31 | $22,000 | −$13,000 | −37.14% |
| 2016 | 2016-12-31 | $35,000 | −$74,000 | −67.89% |
| 2015 | 2015-12-31 | $109,000 | $88,000 | +419.05% |
| 2014 | 2014-12-31 | $21,000 | $11,000 | +110.00% |
| 2013 | 2013-12-31 | $10,000 | $1,000 | +11.11% |
| 2012 | 2012-12-31 | $9,000 | — | — |
Eledon Pharmaceuticals quarterly depreciation and amortization
Q1.14
Q2.14
Q3.14
Q1.15
Q2.15
Q3.15
Q1.16
Q2.16
Q3.16
Q1.17
Q2.17
Q3.17
Q1.18
Q2.18
Q3.18
Q1.19
Q2.19
Q3.19
Q1.20
Q2.20
Q3.20
Q4.24
Q4.25
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $81,000 | −$7,000 | −7.95% |
| Q4 2024 | 2024-12-31 | $88,000 | — | — |
| Q3 2020 | 2020-09-30 | $1,000 | −$2,000 | −66.67% |
| Q2 2020 | 2020-06-30 | $2,000 | $0 | 0.00% |
| Q1 2020 | 2020-03-31 | $2,000 | $0 | 0.00% |
| Q3 2019 | 2019-09-30 | $3,000 | $0 | 0.00% |
| Q2 2019 | 2019-06-30 | $2,000 | $0 | 0.00% |
| Q1 2019 | 2019-03-31 | $2,000 | −$1,000 | −33.33% |
| Q3 2018 | 2018-09-30 | $3,000 | $1,000 | +50.00% |
| Q2 2018 | 2018-06-30 | $2,000 | −$10,000 | −83.33% |
| Q1 2018 | 2018-03-31 | $3,000 | −$1,000 | −25.00% |
| Q3 2017 | 2017-09-30 | $2,000 | −$47,000 | −95.92% |
| Q2 2017 | 2017-06-30 | $12,000 | −$40,000 | −76.92% |
| Q1 2017 | 2017-03-31 | $4,000 | −$49,000 | −92.45% |
| Q3 2016 | 2016-09-30 | $49,000 | $17,000 | +53.13% |
| Q2 2016 | 2016-06-30 | $52,000 | $36,000 | +225.00% |
| Q1 2016 | 2016-03-31 | $53,000 | $48,000 | +960.00% |
| Q3 2015 | 2015-09-30 | $32,000 | $27,000 | +540.00% |
| Q2 2015 | 2015-06-30 | $16,000 | $9,000 | +128.57% |
| Q1 2015 | 2015-03-31 | $5,000 | $1,000 | +25.00% |
| Q3 2014 | 2014-09-30 | $5,000 | — | — |
| Q2 2014 | 2014-06-30 | $7,000 | — | — |
| Q1 2014 | 2014-03-31 | $4,000 | — | — |
Eledon Pharmaceuticals depreciation and amortization trends
Over the last five fiscal years, Eledon Pharmaceuticals's depreciation and amortization increased from $5,000 to $313,000, a change of $308,000. The latest reported quarter, Q4 2025, shows $81,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Eledon Pharmaceuticals source filings ↗